Cargando…
Reporting of adverse reactions to benznidazole: does medical expertise matter?
This study evaluated and compared follow-up and adverse drug reaction (ADR) reporting for Chagas disease (CD) patients treated with benznidazole (BZN) by two health teams with different levels of experience, using medical records for 204 patients participating in the first year of a scaled-up public...
Autores principales: | Pereiro, Ana Cristina, Lenardón, Mabel, Zeballos, Alejandro, Chopita, Marina, Abril, Marcelo, Gold, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Organización Panamericana de la Salud
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385644/ https://www.ncbi.nlm.nih.gov/pubmed/31093097 http://dx.doi.org/10.26633/RPSP.2018.69 |
Ejemplares similares
-
Characterization of adverse reactions to benznidazole in patients
with Chagas disease in the Federal District, Brazil
por: Gontijo, Maria Katarine Costa Lucas, et al.
Publicado: (2020) -
Benznidazole
por: Soares-Sobrinho, José Lamartine, et al.
Publicado: (2008) -
Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole
por: Franco, Lucas A. M., et al.
Publicado: (2021) -
Preclinical pharmacokinetics of benznidazole.
por: Workman, P., et al.
Publicado: (1984) -
Judicial expertise in the post-pandemic era
por: Jakobi, Heinz Roland, et al.
Publicado: (2021)